Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study
Open accessThe DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Abstract
Context: Vitamin B12 deficiency may occur with metformin treatment, but few studies have assessed risk with long-term use. Objective: To assess the risk of B12 deficiency with metformin use in the Diabetes Prevention Program (DPP)/DPP Outcomes Study (DPPOS). Design: Secondary analysis from the DPP/DPPOS. Participants were assigned to the placebo group (PLA) (n = 1082) or the metformin group (MET) (n = 1073) for 3.2 years; subjects in the metformin group received open-label metformin for an additional 9 years. Setting: Twenty-seven study centers in the United States. Patients: DPP eligibility criteria were: elevated fasting glucose, impaired glucose tolerance, and overweight/obesity. The analytic population comprised participants with available stored samples. B12 levels were assessed at 5 years (n = 857, n = 858) and 13 years (n = 756, n = 764) in PLA and MET, respectively. Interventions: Metformin 850 mg twice daily vs placebo (DPP), and open-label metformin in the metformin group (DPPOS). Main Outcome Measures: B12 deficiency, anemia, and peripheral neuropathy. Results: Low B12 (≤ 203 pg/mL) occurred more often in MET than PLA at 5 years (4.3 vs 2.3%; P = .02) but not at 13 years (7.4 vs 5.4%; P = .12). Combined low and borderline-low B12 (≤ 298 pg/mL) was more common in MET at 5 years (19.1 vs 9.5%; P < .01) and 13 years (20.3 vs 15.6%; P = .02). Years of metformin use were associated with increased risk of B12 deficiency (odds ratio, B12 deficiency/year metformin use, 1.13; 95% confidence interval, 1.06–1.20). Anemia prevalence was higher in MET, but did not differ by B12 status. Neuropathy prevalence was higher in MET with low B12 levels. Conclusions: Long-term use of metformin in DPPOS was associated with biochemical B12 deficiency and anemia. Routine testing of vitamin B12 levels in metformin-treated patients should be considered.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Vegetarian and vegan diets are associated with lower risk of DM, and, in persons with DM, these diets have been shown to lower glycemia and improve CVD risk factors.831,833,931,716–720,833,932”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [931]
In the citing paper
“Metformin use may result in lower serum vitamin B12 concentrations and worsening of symptoms of neuropathy; therefore, periodic monitoring and supplementation are generally recommended if levels are de fi cient, particularly in those with anemia or neuropathy (178,179).”
In the citing paper
“Metformin is associated with vitamin B12 de fi ciency, with a recentsystematicreview recommending that annual blood testing of vitamin B12 levels be considered in metformin-treated people, especially in those with anemia or peripheral neuropathy (257).”
From Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report (2019) · cites this paper as [257]
In the citing paper
“This study found that even in theabsenceofanemia,B12de fi ciencywas prevalent.”
From Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report (2019) · cites this paper as [257]
In the citing paper
“Metformin use is also associated with increased risk of vitamin B12 deficiency and worsening of symptoms of neuropathy (102,103), suggesting periodic testing of vitamin B12 levels”
From 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2025 (2025) · cites this paper as [103]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · cited 2×
“The DPP and DPPOS design, eligibility, and baseline characteristics have been reported elsewhere (26, 27).”
Diabetes Prevention Program Research Group (2009) · The Lancet · doi:10.1016/s0140-6736(09)61457-4 · Cited by 3,020
Feldman, E. L., Stevens, M. J., Thomas, P. K., Brown, M. B., Canal, N., & Greene, D. A. (1994) · Diabetes Care · doi:10.2337/diacare.17.11.1281 · Cited by 1,293 · cited 1×
“The Michigan Neuropathy Screening Instrument (MNSI) was conducted annually and was analyzed for DPPOS years 1 and 9, concurrent with B12 measurements (30).”
de Jager, J., Kooy, A., Lehert, P., Wulffele, M. G., van der Kolk, J., Bets, D., Verburg, J., Donker, A. J. M., & Stehouwer, C. D. A. (2010) · BMJ · doi:10.1136/bmj.c2181 · Cited by 702 · cited 1×
“3 years, metformin reduced vitamin B12 concentration by 19%, increased homocysteine concentration by 5%, and was associated with an 11-fold increased risk in low vitamin B12 levels compared to placebo (19).”
Increased intake of calcium reverses vitamin B12 malabsorption induced by metformin
Bauman, W. A., Shaw, S., Jayatilleke, E., Spungen, A. M., & Herbert, V (2000) · Diabetes Care · doi:10.2337/diacare.23.9.1227 · Cited by 412
Risk Factors of Vitamin B12 Deficiency in Patients Receiving Metformin
Ting, R. Z.-W. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.18.1975 · Cited by 333
Wile, D. J., & Toth, C. (2010) · Diabetes Care · doi:10.2337/dc09-0606 · Cited by 283 · cited 1×
“In a prospective case control study of diabetic patients referred for treatment of symptomatic peripheral neuropathy, metformin-treated patients had lower vitamin B12 levels and elevated methylmalonic acid and homocysteine levels, along with clinical and electrophysiological evidence of more severe peripheral neuropat…”
Association of Biochemical B12 Deficiency With Metformin Therapy and Vitamin B12 Supplements
Reinstatler, L., Qi, Y. P., Williamson, R. S., Garn, J. V., & Oakley, G. P. (2012) · Diabetes Care · doi:10.2337/dc11-1582 · Cited by 265
Wulffelé, M. G., Kooy, A., Lehert, P., Bets, D., Ogterop, J. C., Borger van der Burg, B., Donker, A. J. M., & Stehouwer, C. D. A. (2003) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01213.x · Cited by 244
Vitamin-B 12 Status of Patients on Long-term Metformin Therapy
Tomkin, G. H., Hadden, D. R., Weaver, J. A., & Montgomery, D. A. D. (1971) · BMJ · doi:10.1136/bmj.2.5763.685 · Cited by 225 · cited 1×
“As early as 1971, Tomkin et al (2) recommended that all patients on longterm metformin therapy have annual serum B12 testing, based on a cross-sectional evaluation.”
Cited by
Davies, M. J., D’Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J., & Buse, J. B. (2018) · Diabetes Care · doi:10.2337/dci18-0033 · Cited by 3,518
Davies, M. J., Aroda, V. R., Collins, B. S., Gabbay, R. A., Green, J., Maruthur, N. M., Rosas, S. E., Del Prato, S., Mathieu, C., Mingrone, G., et al. (2022) · Diabetes Care · doi:10.2337/dci22-0034 · Cited by 2,104
Self-citation9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s009 · Cited by 1,555
Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report
Evert, A. B., Dennison, M., Gardner, C. D., Garvey, W. T., Lau, K. H. K., MacLeod, J., Mitri, J., Pereira, R. F., Rawlings, K., Robinson, S., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0014 · Cited by 1,496
Davies, M. J., D’Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J., & Buse, J. B. (2018) · Diabetologia · doi:10.1007/s00125-018-4729-5 · Cited by 1,455
Metformin as a tool to target aging
Barzilai, N., Crandall, J. P., Kritchevsky, S. B., & Espeland, M. A. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.011 · Cited by 1,096
“Further, the risk of lactic acidosis appears to be related to renal function, not age per se, and is currently considered to be very low (Aroda et al., 2016).”
Self-citationDavies, M. J., Aroda, V. R., Collins, B. S., Gabbay, R. A., Green, J., Maruthur, N. M., Rosas, S. E., Del Prato, S., Mathieu, C., Mingrone, G., et al. (2022) · Diabetologia · doi:10.1007/s00125-022-05787-2 · Cited by 1,048
“Metformin use may result in lower serum vitamin B12 concentrations and worsening of symptoms of neuropathy; therefore, periodic monitoring and supplementation are generally recommended if levels are deficient, particularly in those with anaemia or neuropathy [178, 179].”
Self-citation9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s009 · Cited by 972
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s009 · Cited by 914
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s009 · Cited by 851
Self-citationBenefits of Metformin in Attenuating the Hallmarks of Aging
Kulkarni, A. S., Gubbi, S., & Barzilai, N. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.04.001 · Cited by 766
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s009 · Cited by 739
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Bajaj, M., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s009 · Cited by 728
8. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s008 · Cited by 699
5. Lifestyle Management:Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s005 · Cited by 700
“ing of vitamin B12 levels should be considered in patients taking metformin, particularly in those with anemia or peripheral neuropathy (123).”
BackgroundAging and age‐related diseases: from mechanisms to therapeutic strategies
Li, Z., Zhang, Z., Ren, Y., Wang, Y., Fang, J., Yue, H., Ma, S., & Guan, F. (2021) · Biogerontology · doi:10.1007/s10522-021-09910-5 · Cited by 640
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Gaglia, J. L., Hilliard, M. E., Johnson, E. L., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s009 · Cited by 662
Berger, M. M., Shenkin, A., Schweinlin, A., Amrein, K., Augsburger, M., Biesalski, H.-K., Bischoff, S. C., Casaer, M. P., Gundogan, K., Lepp, H.-L., et al. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.02.015 · Cited by 615
Metformin: clinical use in type 2 diabetes
Sanchez-Rangel, E., & Inzucchi, S. E. (2017) · Diabetologia · doi:10.1007/s00125-017-4336-x · Cited by 595
“Nonetheless, based on the biochemical changes and given the potential irreversible neurological sequelae from unrecognised vitamin B12 deficiency, it is suggested that periodic testing of vitamin B12 levels be performed in patients on long-term metformin therapy, especially in those with anaemia or peripheral neuropat…”
BackgroundTreatment of Diabetes in Older Adults: An Endocrine Society* Clinical Practice Guideline
LeRoith, D., Biessels, G. J., Braithwaite, S. S., Casanueva, F. F., Draznin, B., Halter, J. B., Hirsch, I. B., McDonnell, M. E., Molitch, M. E., Murad, M. H., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00198 · Cited by 568
“Glyburide should be avoided in older individuals because of a substantially increased risk of hypoglycemia compared with that of glimepiride and glipizide (130, 131, 134, 135).”
Background4. Lifestyle Management: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s004 · Cited by 563
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
8. Pharmacologic Approaches to Glycemic Treatment
American Diabetes Association (2017) · Diabetes Care · doi:10.2337/dc17-s011 · Cited by 458
B Vitamins and One-Carbon Metabolism: Implications in Human Health and Disease
Lyon, P., Strippoli, V., Fang, B., & Cimmino, L. (2020) · Nutrients · doi:10.3390/nu12092867 · Cited by 437
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s005 · Cited by 445
13. Older Adults: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s013 · Cited by 381
Biomarkers and Algorithms for the Diagnosis of Vitamin B12 Deficiency
Hannibal, L., Lysne, V., Bjørke-Monsen, A.-L., Behringer, S., Grünert, S. C., Spiekerkoetter, U., Jacobsen, D. W., & Blom, H. J. (2016) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2016.00027 · Cited by 355
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s005 · Cited by 362
Self-citationPetrie, J. R., Chaturvedi, N., Ford, I., Brouwers, M. C. G. J., Greenlaw, N., Tillin, T., Hramiak, I., Hughes, A. D., Jenkins, A. J., Klein, B. E. K., et al. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30194-8 · Cited by 357
“…contribute to growing evidence that treatment with metformin reduces vitamin B12 concentrations, suggesting that monitoring should be used during long-term use, 7,31,32 particularly in type 1 diabetes, in which there is associated risk of gastroparesis, pernicious anaemia, and coeliac disease.”
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s005 · Cited by 339
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Beverly, E. A., Bruemmer, D., Collins, B. S., Darville, A., Ekhlaspour, L., Hassanein, M., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s005 · Cited by 285
9. pharmacologic approaches to glycemic treatment: standards of care in diabetes—2026
American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, M., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Briggs Early, K., ChallaSivaKanaka, S., et al. (2026) · Diabetes Care · doi:10.2337/dc26-s009 · Cited by 263
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s005 · Cited by 299
American Diabetes Association (2017) · Diabetes Care · doi:10.2337/dc17-s007 · Cited by 281
Mohammed, I., Hollenberg, M. D., Ding, H., & Triggle, C. R. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.718942 · Cited by 278
Metformin as Anti-Aging Therapy: Is It for Everyone?
Soukas, A. A., Hao, H., & Wu, L. (2019) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2019.07.015 · Cited by 263
“accompanied by neuropathy or anemia [11].”
BackgroundPharmacologic Glycemic Management of Type 2 Diabetes in Adults
Lipscombe, L., Booth, G., Butalia, S., Dasgupta, K., Eurich, D. T., Goldenberg, R., Khan, N., MacCallum, L., Shah, B. R., & Simpson, S. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.034 · Cited by 246
Long-term metformin therapy and vitamin B12 deficiency: an association to bear in mind
Infante, M., Leoni, M., Caprio, M., & Fabbri, A. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i7.916 · Cited by 222
13. Older Adults: Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s013 · Cited by 199
Self-citation3. Prevention or Delay of Diabetes and Associated Comorbidities: Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Gaglia, J. L., Hilliard, M. E., Isaacs, D., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s003 · Cited by 204
Self-citation13. Older Adults: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s013 · Cited by 209
3. Prevention or Delay of Type 2 Diabetes:Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s003 · Cited by 200
Strain, W. D., Down, S., Brown, P., Puttanna, A., & Sinclair, A. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01035-9 · Cited by 194
for the Diabetes Prevention Program Research Group, Aroda, V. R., Knowler, W. C., Crandall, J. P., Perreault, L., Edelstein, S. L., Jeffries, S. L., Molitch, M. E., Pi-Sunyer, X., Darwin, C., et al. (2017) · Diabetologia · doi:10.1007/s00125-017-4361-9 · Cited by 194
“Anaemia prevalence was higher in the metformin group but, importantly, did not differ by vitamin B12 level, suggesting that haematological monitoring may not be sufficient to detect metformin-associated vitamin B12 deficiency [36].”
BackgroundSelf-citationFeng, J., Wang, X., Ye, X., Ares, I., Lopez-Torres, B., Martínez, M., Martínez-Larrañaga, M.-R., Wang, X., Anadón, A., & Martínez, M.-A. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106114 · Cited by 194
Should metformin remain the first-line therapy for treatment of type 2 diabetes?
Baker, C., Retzik-Stahr, C., Singh, V., Plomondon, R., Anderson, V., & Rasouli, N. (2021) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018820980225 · Cited by 181
Association between metformin dose and vitamin B12 deficiency in patients with type 2 diabetes
Kim, J., Ahn, C. W., Fang, S., Lee, H. S., & Park, J. S. (2019) · Medicine · doi:10.1097/md.0000000000017918 · Cited by 179
“Since large prospective studies have clarified this relationship recently,([9,10]) the 2017 American Diabetes Association treatment guidelines now recommend regular monitoring of vitamin B12 levels in patients with diabetes taking metformin.”
BackgroundChen, H., Huang, X., Dong, M., Wen, S., Zhou, L., & Yuan, X. (2023) · Diabetes, Metabolic Syndrome and Obesity · doi:10.2147/dmso.s410834 · Cited by 159
“dysgeusia, hyperoxia, and vitamin b12 deficiency may hamper their prospect widely utilization in these populations.(150) Sulfonylureas predispose to muscle atrophy and should be avoided in patients with sarcopenia or in patients with diabetes at risk of developing sarcopenia.”
BackgroundDidangelos, T., Karlafti, E., Kotzakioulafi, E., Margariti, E., Giannoulaki, P., Batanis, G., Tesfaye, S., & Kantartzis, K. (2021) · Nutrients · doi:10.3390/nu13020395 · Cited by 163
“From these studies, it has become apparent that metformin causes vitamin B12 deficiency in a dose- and duration of treatment-dependent manner [24], and that although it may occur as early as only four months after the initiation of metformin, vitamin B12 deficiency appears usually after at least four-to-five years of…”
BackgroundThe Current and Potential Therapeutic Use of Metformin—The Good Old Drug
Drzewoski, J., & Hanefeld, M. (2021) · Pharmaceuticals · doi:10.3390/ph14020122 · Cited by 193
Nicolau, J. C., Feitosa, G. S., Petriz, J. L. F., Furtado, R. H. D. M., Précoma, D. B., Lemke, W., Lópes, R. D., Timerman, A., Marin‐Neto, J. A., Bezerra, L., et al. (2021) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20210180 · Cited by 322
13. Older Adults: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s013 · Cited by 161
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s003 · Cited by 132
3. Prevention or Delay of Diabetes and Associated Comorbidities: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Ebekozien, O., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s003 · Cited by 144
3. Prevention or Delay of Diabetes and Associated Comorbidities: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Gaglia, J. L., Hilliard, M. E., Johnson, E. L., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s003 · Cited by 144
Causes, Consequences and Public Health Implications of Low B-Vitamin Status in Ageing
Porter, K. M., Hoey, L., Hughes, C., Ward, M., & McNulty, H. (2016) · Nutrients · doi:10.3390/nu8110725 · Cited by 160
“In addition, metformin usage in Type 2 Diabetes can also result in vitamin B12 deficiency, possibly interfering with calcium-dependent membrane action in the terminal ileum required for the absorption of the vitamin B12-intrinsic factor complex [46,47].”
BackgroundCefalu, W. T., Buse, J. B., Tuomilehto, J., Fleming, G. A., Ferrannini, E., Gerstein, H. C., Bennett, P. H., Ramachandran, A., Raz, I., Rosenstock, J., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0873 · Cited by 142
Espino-González, E., Dalbram, E., Mounier, R., Gondin, J., Farup, J., Jessen, N., & Treebak, J. T. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.02.014 · Cited by 153
Chamberlain, J. J., Herman, W. H., Leal, S., Rhinehart, A. S., Shubrook, J. H., Skolnik, N., & Kalyani, R. R. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2937 · Cited by 127
3. Prevention or Delay of Type 2 Diabetes: Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s003 · Cited by 124
“Consider monitoring vitamin B12 levels in those taking metformin chronically to check for possible deficiency (54) (see Section 9”
BackgroundManagement of Type 2 Diabetes Mellitus in Elderly Patients with Frailty and/or Sarcopenia
Sanz‐Cánovas, J., Sampalo, A. L., Cobos-Palacios, L., Ricci, M., Hernández-Negrín, H., Mancebo-Sevilla, J. J., Álvarez-Recio, E., Lopez-Carmona, M. D., Perez-Belmonte, L. M., Gómez‐Huelgas, R., et al. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19148677 · Cited by 152
“However, in the elderly, inconveniences such as digestive intolerance, dysgeusia, hyporexia, and vitamin b12 deficiency may appear [64].”
BackgroundInsulin Resistance Exacerbates Alzheimer Disease via Multiple Mechanisms
Wei, Z., Koya, J., & Reznik, S. E. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.687157 · Cited by 115
“Interestingly, T2DM patients with long-term use of metformin have been reported to slightly increase the risk of AD (Imfeld et al., 2012) due to metformin-induced vitamin B12 deficiency (Aroda et al., 2016; Campbell et al., 2018).”
BackgroundLi, Z., Gueant-Rodriguez, R.-M., Quilliot, D., Sirveaux, M.-A., Meyre, D., Gueant, J.-L., & Brunaud, L. (2018) · Clinical Nutrition · doi:10.1016/j.clnu.2017.07.008 · Cited by 113
“821), in contrast to other studies for which type 2 diabetes was the main recruitment criteria [19,20].”
ResultAras, M., Tchang, B. G., & Pape, J. (2021) · Nursing Clinics of North America · doi:10.1016/j.cnur.2021.07.008 · Cited by 108
Doyle-Delgado, K., Chamberlain, J. J., Shubrook, J. H., Skolnik, N., & Trujillo, J. (2020) · Annals of Internal Medicine · doi:10.7326/m20-2470 · Cited by 111
Yang, W., Cai, X., Wu, H., & Ji, L. (2019) · Journal of Diabetes · doi:10.1111/1753-0407.12900 · Cited by 110
“Considering the growing populations taking long-term metformin,(41) many of whom are >60 years of age,(8,11,12,14,17,22,25,27,28) the irreversible neuropathy that could be caused by vitamin B12 deficiency, 43 and the easily available vitamin B12 test, 46 we recommend annual monitoring of vitamin B12 levels in patients…”
BackgroundInfluentialCurrent Concepts in Pharmacometabolomics, Biomarker Discovery, and Precision Medicine
Beger, R. D., Schmidt, M. A., & Kaddurah‐Daouk, R. (2020) · Metabolites · doi:10.3390/metabo10040129 · Cited by 117
César, M. J. P., Molina‐Vega, M., Suárez-Arana, M., González‐Mesa, E., Sola-Moyano, A. P., Roldan-López, R., Romero-Narbona, F., Olveira, G., Tinahones, F. J., & González‐Romero, S. (2021) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.04.229 · Cited by 111
Vitamin B12 deficiency and diabetic neuropathy in patients taking metformin: a cross-sectional study
Álvarez, M., Rincón-Sierra, O., Saavedra, G., & Moreno, S. (2019) · Endocrine Connections · doi:10.1530/ec-19-0382 · Cited by 97
Bell, D. S. H. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14734 · Cited by 107
“20) and the prevalence of neuropathy was higher in those taking metformin.(40) In addition, a prospective case-control study of patients with type 2 diabetes and symptomatic peripheral neuropathy showed that utilization of metformin for more than 6 months (average total dose”
BackgroundPing, F., Jiang, N., & Li, Y. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001370 · Cited by 100
13. Older Adults: Standards of Care in Diabetes—2026
American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, M., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Briggs Early, K., ChallaSivaKanaka, S., et al. (2026) · Diabetes Care · doi:10.2337/dc26-s013 · Cited by 87
Owen, M. D., Baker, B., SCOTT, E. M., & Forbes, K. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115759 · Cited by 98
“2016 [58] 1800 patients participating in the Diabetes Prevention Program (DPP)/DPP Outcomes Study (DPPOS) - 1217 female - 583 male 3.”
BackgroundInfluentialOut, M., Kooy, A., Lehert, P., Schalkwijk, C. A., & Stehouwer, C. D. A. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.11.001 · Cited by 84
Association between neuropathy and B‐vitamins: A systematic review and meta‐analysis
Stein, J., Geisel, J., & Obeid, R. (2021) · European Journal of Neurology · doi:10.1111/ene.14786 · Cited by 84
Association between metformin and vitamin B12 deficiency in patients with type 2 diabetes
Sayedali, E., Yalın, A. E., & Yalın, S. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i5.585 · Cited by 106
Long-term use of metformin and Alzheimer’s disease: beneficial or detrimental effects
Al-Kuraishy, H. M., Al-Gareeb, A. I., Saad, H. M., & Batiha, G. E. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01163-7 · Cited by 82
“3% of patients on metformin therapy (Aroda et al. 2016).”
Moon, J. S., Kang, S., Choi, J. H., Lee, K. A., Moon, J. H., Chon, S., Kim, D. J., Kim, H. J., Seo, J. A., Kim, M. K., et al. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2024.0249 · Cited by 90
Blumberg, J., Bailey, R., Sesso, H., & Ulrich, C. (2018) · Nutrients · doi:10.3390/nu10020248 · Cited by 74
Donnan, K., & Segar, L. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.01.002 · Cited by 76
“In T2D, the increase in fasting plasma glucose concentration results from enhanced hepatic glucose output, which in turn is primarily due to increased gluconeogenesis in insulin-resistant state (Bailey and Turner, 1996).”
Review of Metformin Use for Type 2 Diabetes Prevention
Moin, T., Schmittdiel, J. A., Flory, J. H., Yeh, J., Karter, A. J., Kruge, L. E., Schillinger, D., Mangione, C. M., Herman, W. H., & Walker, E. A. (2018) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2018.04.038 · Cited by 75
Maniar, K., Moideen, A., Mittal, A., Patil, A., Chakrabarti, A., & Banerjee, D. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.12.003 · Cited by 77
Nutritional Strategies for the Management of Type 2 Diabetes Mellitus: A Narrative Review
Minari, T. P., Tácito, L. H. B., Yugar, L. B. T., Ferreira‐Melo, S. E., Manzano, C. F., Pires, A. C., Moreno, H., Vilela-Martin, J. F., Cosenso‐Martin, L. N., & Yugar‐Toledo, J. C. (2023) · Nutrients · doi:10.3390/nu15245096 · Cited by 103
Borges-Vieira, J. G., & Cardoso, C. K. S. (2022) · Nutritional Neuroscience · doi:10.1080/1028415x.2022.2031494 · Cited by 80
ESPEN practical short micronutrient guideline
Berger, M. M., Shenkin, A., Dizdar, O. S., Amrein, K., Augsburger, M. P., Biesalski, H. K., Bischoff, S. C., Casaer, M. P., Gündoğan, K., Lepp, H.-L., et al. (2024) · Clinical Nutrition · doi:10.1016/j.clnu.2024.01.030 · Cited by 93
Miranda, C. L., Johnson, L. A., de Montgolfier, O., Elias, V. D., Ullrich, L. S., Hay, J. J., Paraiso, I. L., Choi, J., Reed, R. L., Revel, J. S., et al. (2018) · Scientific Reports · doi:10.1038/s41598-017-18992-6 · Cited by 86
Porter, K. M., Ward, M., Hughes, C., O’Kane, M., Hoey, L., McCann, A., Molloy, A. M., Cunningham, C. J., Casey, M. C., Tracey, F., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01791 · Cited by 81
Hemmingsen, B., Sonne, D. P., Metzendorf, M.-I., & Richter, B. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012151.pub2 · Cited by 60
Metformin and Type 2 Diabetes Prevention
Aroda, V. R., & Ratner, R. E. (2018) · Diabetes Spectrum · doi:10.2337/ds18-0020 · Cited by 70
Self-citationMadsen, K. S., Chi, Y., Metzendorf, M.-I., Richter, B., & Hemmingsen, B. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008558.pub2 · Cited by 70
Risk of Anemia With Metformin Use in Type 2 Diabetes: A MASTERMIND Study
Donnelly, L. A., Dennis, J., Coleman, R. L., Sattar, N. A., Hattersley, A. T., Holman, R. R., & Pearson, E. R. (2020) · Diabetes Care · doi:10.2337/dc20-1104 · Cited by 70
Didangelos, T., Karlafti, E., Kotzakioulafi, E., Kontoninas, Z., Margaritidis, C., Giannoulaki, P., & Kantartzis, K. (2020) · Nutrients · doi:10.3390/nu12113254 · Cited by 76
“In addition, vitamin B12 (B12) levels are often low in DM patients, due to metformin treatment as the first-line agent of diabetes treatment [31] and is also commonly for the use of proton pumps inhibitors (PPIs) [32].”
BackgroundObeid, R., Andrès, E., Češka, R., Hooshmand, B., Guéant‐Rodriguez, R., Prada, G. I., Sławek, J. W., Traykov, L. D., Van, B. T., Várkonyi, T. T., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13082176 · Cited by 88
“Low serum vitamin B12 concentrations in people using metformin are associated with hyperhomocysteinemia [48], a higher incidence of neuropathy [49,50], and worse neuropathy scores [51].”
BackgroundSelf-citationInteractions between Food and Drugs, and Nutritional Status in Renal Patients: A Narrative Review
D’Alessandro, C., Benedetti, A., Di Paolo, A., Giannese, D., & Cupisti, A. (2022) · Nutrients · doi:10.3390/nu14010212 · Cited by 66
“, trifluoroperazine), colchicine, estrogens and metformin [44].”
Metformin for diabetes prevention: update of the evidence base
Gottwald‐Hostalek, U., & Campbell, I. W. (2021) · Current Medical Research and Opinion · doi:10.1080/03007995.2021.1955667 · Cited by 80
Ha, J.-H., Choi, D., Kim, K. J., Cho, S. Y., Kim, H., Kim, K. Y., Koh, Y., Nam, C. M., & Kim, E. (2021) · Scientific Reports · doi:10.1038/s41598-021-03406-5 · Cited by 67
3. Prevention or Delay of Diabetes and Associated Comorbidities: Standards of Care in Diabetes—2026
Bajaj, M. S., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Early, K. B., ChallaSivaKanaka, S., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc26-s003 · Cited by 104
Wee, A. K. H. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110374 · Cited by 66
Gharibzahedi, S. M. T., Moghadam, M. R. F., Amft, J., Tolun, A., Hasabnis, G. K., & Altıntaş, Z. (2023) · Molecules · doi:10.3390/molecules28227469 · Cited by 65
“Aroda et al. [76] showed that metformin could curtail the absorption of VB 12 .”
BackgroundMetformin: Past, Present, and Future
Chaudhary, S., & Kulkarni, A. (2024) · Current Diabetes Reports · doi:10.1007/s11892-024-01539-1 · Cited by 68
Metadata
- Authors
- Aroda, V. R., Edelstein, S. L., Goldberg, R. B., Knowler, W. C., Marcovina, S. M., Orchard, T. J., Bray, G. A., Schade, D. S., Temprosa, M. G., White, N. H., Crandall, J. P., & the Diabetes Prevention Program Research Group
- Affiliations
- MedStar Health Research Institute (US)
- George Washington University (US)
- University of Miami (US)
- National Institute of Diabetes and Digestive and Kidney Diseases (US)
- University of Washington (US)
- University of Pittsburgh (US)
- Pennington Biomedical Research Center (US)
- University of New Mexico (US)
- Washington University in St. Louis (US)
- Albert Einstein College of Medicine (US)
- Corresponding author
- Crandall, Jill P.
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2016-04-01
- Volume
- 101
- Issue
- 4
- Pages
- 1754-1761
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC4880159
- OpenAlex
- W2275928777
- Cited by
- 536
- References
- 42
- Citations by year
- 2026: 51 · 2025: 47 · 2024: 64 · 2023: 68 · 2022: 58 · 2021: 78 · 2020: 56 · 2019: 40 · 2018: 35 · 2017: 24 · 2016: 15
- FWCI
- 40.44
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (UL1TR001409)
- National Institute of Diabetes and Digestive and Kidney Diseases (U01DK048375, U01DK048397, U01DK048406, U01DK048413, R01DK078907, U01DK048485, U01DK048400, U01DK048434, U01DK048380, U01DK048412, U01DK048411, U01DK048377, U01DK048437, U01DK048514, U01DK048489, U01DK048468, U01DK048407, U01DK048381, U01DK048443, U01DK048349, U01DK048387, U01DK048404, P30DK017047, P30DK020541)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Folate and B Vitamins Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Porphyrin Metabolism and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- metformin, vitamin B12 deficiency, anemia, peripheral neuropathy, impaired glucose tolerance, type 2 diabetes prevention, Diabetes Prevention Program Outcomes Study, drug safety, impaired fasting glucose, overweight and obesity
- MeSH terms
- Adult, Aged, Anemia, Diabetes Mellitus, Type 2, Female, Homocysteine, Humans, Hypoglycemic Agents, Male, Metformin, Middle Aged, Vitamin B 12, Vitamin B 12 Deficiency
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.